Dodecanedioic acid prevents and reverses metabolic‐associated liver disease and obesity and ameliorates liver fibrosis in a rodent model of diet‐induced obesity
Giulia Angelini(Università Cattolica del Sacro Cuore), Geltrude Mingrone(University of the Sacred Heart), Fabrizia Carli(Istituto di Fisiologia Clinica), Maria Emiliana Caristo(Università Cattolica del Sacro Cuore), Erminia Lembo(Università Cattolica del Sacro Cuore), Amalia Gastaldelli(National Research Council), Roberta Calce(Università Cattolica del Sacro Cuore), Simona Panunzi(Istituto di Analisi dei Sistemi ed Informatica Antonio Ruberti), Patrizia Infelise(Istituto di Fisiologia Clinica), Stefan R. Bornstein(King's College London), Sara Russo(Università Cattolica del Sacro Cuore), A. Bertuzzi(Institute for Systems Analysis)
Cited by 8
Related Papers
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
|Diabetes Care|2022|1.9k
Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline
|The Journal of Clinical Endocrinology & Metabolism|2016|1.7k
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
Definition and diagnostic criteria of clinical obesity
|The Lancet Diabetes & Endocrinology|2025|1.5k
Joint international consensus statement for ending stigma of obesity
|Nature Medicine|2020|1.1k